Plaintiff Wins $150 Million in AndroGel Lawsuit

January 4, 2018  |  Dangerous Drugs & Devices, Pharmaceuticals
Androgel Verdict

An Oregon couple won a $150 million lawsuit against AbbVie Inc., the maker of the testosterone therapy medication AndroGel. The plaintiffs claimed that the man developed severe heart issues after taking the drug and an Illinois jury agreed.

Thousands of Lawsuits

This is one of more than 7,000 lawsuits that have been filed against the makers of medications meant to treat the symptoms of low testosterone, or Low-T. These lawsuits have been consolidated into a multi-district litigation, or MDL, case. It is being heard in the Northern District of Illinois.

Plaintiffs are alleging that manufacturers misled doctors and their patients in an effort to market their testosterone therapy drugs. They allege that these products were advertised in a misleading fashion in an effort to convince middle-aged men there was a solution to their Low-T-related problems, such as constant fatigue and a lack of sex drive.

The Oregon couple claimed that the man decided to take AndroGel after seeing an advertisement. He received a prescription from his doctor and used the drug for four years. It was during this time, he alleged, that he started suffering from heart problems.

They claimed that AbbVie was negligent in developing AndroGel and also misrepresented the benefits of the drug in a fraudulent and negligent manner.

If you suffered health problems after taking a Low-T drug, you might be able to take legal action in the form of a testosterone therapy lawsuit. Please contact Baron & Budd to learn more about how we might be able to help. Give us a call at 866-520-2755 or complete our contact form.

News Articles

View All
  • Get Answers Now

    Get a free case evaluation to help determine your legal rights.

  • Receive emails from Baron & Budd?
  • Receive text messages from Baron & Budd?
  • This field is for validation purposes and should be left unchanged.